Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Spencer Robert BerthelsenIndependent Director | -8,00k | 410,00k | Derivative Exercise and Sale | 24,42 - 75,67 | 156,08k | - |
| 2026-05-13 | Dr. Brett P. MoniaFounder, CEO & Director | -4,54k | 208,14k | Derivative Exercise and Sale | 32,60 - 78,68 | 242,66k | - |
| 2026-05-04 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -77,29k | 2,03M | Derivative Exercise and Sale | 38,06 - 75,58 | 36,33k | - |
| 2026-05-01 | Mr. Joseph KleinIndependent Director | -10,11k | 266,91k | Derivative Exercise and Sale | 47,11 - 74,45 | 11,11k | - |
| 2026-04-28 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1,63k | 116,73k | Automatic Disposition | 71,79 | 49,26k | -3,20% |
| 2026-04-15 | Ms. B. Lynne ParshallDirector | -5,00k | 381,37k | Automatic Disposition | 76,19 - 76,97 | 51,34k | -8,87% |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -4,90k | 368,49k | Derivative Exercise and Sale | 75,17 | 23,71k | - |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 7,32k | 0,00 | Derivative Exercise and Retained Stock | - | 23,71k | 44,69% |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5,62k | 418,95k | Derivative Exercise and Sale | 74,56 | 50,88k | - |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 5,22k | 0,00 | Derivative Exercise and Retained Stock | - | 50,88k | 11,43% |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -973,00 | 73,02k | Derivative Exercise and Sale | 75,04 | 67,50k | - |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 902,00 | 0,00 | Derivative Exercise and Retained Stock | - | 67,50k | 1,35% |
| 2026-04-01 | Mr. Joseph KleinIndependent Director | -22,32k | 805,60k | Derivative Exercise and Sale | 38,06 - 75,95 | 11,11k | - |
| 2026-04-02 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -6,19k | 458,61k | Automatic Disposition | 74,05 | 16,35k | -27,47% |
| 2026-03-19 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -5,81k | 412,49k | Automatic Disposition | 70,97 | 63,89k | -8,34% |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -175,00k | 3,68M | Derivative Exercise and Sale | 32,60 - 72,38 | 82,66k | - |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -50,22k | 3,65M | Automatic Disposition | 72,38 - 73,21 | 82,66k | -37,79% |
| 2026-03-10 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -37,28k | 1,16M | Derivative Exercise and Sale | 34,69 - 76,30 | 16,39k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -148,45k | 2,15M | Derivative Exercise and Sale | 60,89 - 76,34 | 242,66k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -12,32k | 927,65k | Automatic Disposition | 75,26 - 75,58 | 242,66k | -4,83% |
| 2026-03-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10,15k | 763,66k | Automatic Disposition | 75,25 | 62,21k | -14,02% |
| 2026-03-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -1,03k | 43,55k | Derivative Exercise and Sale | 38,06 - 80,33 | 36,33k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -2,14k | 76,45k | Derivative Exercise and Sale | 32,60 - 80,41 | 45,66k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -4,52k | 359,25k | Automatic Disposition | 79,36 - 81,01 | 45,66k | -9,01% |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65,09k | 1,65M | Derivative Exercise and Sale | 32,60 - 79,10 | 80,55k | - |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20,00k | 1,59M | Automatic Disposition | 79,10 - 80,76 | 80,55k | -19,89% |
| 2026-03-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -20,11k | 873,18k | Derivative Exercise and Sale | 32,60 - 80,84 | 22,54k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -40,32k | 1,59M | Derivative Exercise and Sale | 38,06 - 79,88 | 3,81k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -14,56k | 1,16M | Automatic Disposition | 79,88 - 80,80 | 3,81k | -79,25% |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -16,00k | 616,70k | Derivative Exercise and Sale | 40,05 - 80,00 | 11,11k | - |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -5,33k | 427,37k | Automatic Disposition | 80,00 - 80,82 | 11,11k | -32,42% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 0,00 | 0,00 | Other Disposition | - | 100,29k | 0,00% |
| 2026-02-11 | Ms. B. Lynne ParshallDirector | -5,00k | 413,59k | Automatic Disposition | 82,72 | 56,34k | -8,15% |
| 2026-02-13 | Dr. Eric E. SwayzeExec. VP of Research | -15,64k | 1,28M | Automatic Disposition | 81,56 - 82,07 | 32,42k | -32,54% |
| 2026-02-06 | Dr. Brett P. MoniaFounder, CEO & Director | -29,43k | 2,52M | Automatic Disposition | 85,79 | 254,50k | -10,37% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65,09k | 1,91M | Derivative Exercise and Sale | 32,60 - 83,03 | 100,29k | - |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20,00k | 1,65M | Verkauf | 82,60 | 100,29k | -16,63% |
| 2026-01-30 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -6,18k | 513,05k | Verkauf | 83,03 | 66,25k | -8,53% |
| 2026-01-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -6,99k | 581,70k | Verkauf | 83,24 | 132,88k | -5,00% |
| 2026-01-30 | Dr. Brett P. MoniaFounder, CEO & Director | -62,97k | 5,21M | Verkauf | 82,72 | 283,93k | -18,15% |
| 2026-01-30 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -6,18k | 515,63k | Verkauf | 83,45 | 69,70k | -8,14% |
| 2026-01-30 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -6,18k | 516,15k | Verkauf | 83,53 | 71,98k | -7,91% |
| 2026-01-30 | Dr. Eric E. SwayzeExec. VP of Research | -6,18k | 512,45k | Verkauf | 82,93 | 48,07k | -11,39% |
| 2026-01-30 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5,30k | 439,36k | Verkauf | 82,96 | 50,19k | -9,55% |
| 2026-01-30 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5,89k | 488,14k | Verkauf | 82,95 | 100,29k | -5,54% |
| 2026-01-22 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3,98k | 323,49k | Automatic Disposition | 81,34 | 22,54k | -15,00% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | 11,54k | 0,00 | Derivative Exercise and Retained Stock | - | 42,25k | 37,59% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | -9,93k | 748,38k | Derivative Exercise and Sale | 75,34 - 75,97 | 42,25k | - |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | 12,38k | 0,00 | Derivative Exercise and Retained Stock | - | 63,89k | 24,04% |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9,30k | 703,14k | Derivative Exercise and Sale | 75,59 | 63,89k | - |
| 2026-01-15 | Mr. Michael J. YangIndependent Director | 1,93k | 0,00 | Derivative Exercise and Retained Stock | - | 7,94k | 32,11% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | 45,11k | 0,00 | Derivative Exercise and Retained Stock | - | 224,68k | 25,12% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | -44,03k | 3,29M | Derivative Exercise and Sale | 74,82 | 224,68k | - |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | 12,28k | 0,00 | Derivative Exercise and Retained Stock | - | 66,17k | 22,79% |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -9,19k | 697,05k | Derivative Exercise and Sale | 75,84 | 66,17k | - |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | 15,81k | 0,00 | Derivative Exercise and Retained Stock | - | 126,31k | 14,30% |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -12,92k | 971,99k | Derivative Exercise and Sale | 75,22 | 126,31k | - |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | 6,98k | 0,00 | Derivative Exercise and Retained Stock | - | 14,72k | 90,16% |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | -4,14k | 313,31k | Derivative Exercise and Sale | 75,66 | 14,72k | - |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 5,19k | 0,00 | Derivative Exercise and Retained Stock | - | 16,39k | 46,34% |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -1,82k | 138,48k | Derivative Exercise and Sale | 75,96 | 16,39k | - |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 11,83k | 0,00 | Derivative Exercise and Retained Stock | - | 45,20k | 35,45% |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -8,06k | 610,28k | Derivative Exercise and Sale | 75,75 - 75,78 | 45,20k | - |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 11,61k | 0,00 | Derivative Exercise and Retained Stock | - | 60,44k | 23,78% |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8,48k | 636,93k | Derivative Exercise and Sale | 75,11 | 60,44k | - |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 12,08k | 0,00 | Derivative Exercise and Retained Stock | - | 94,76k | 14,61% |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -8,98k | 674,62k | Derivative Exercise and Sale | 75,15 | 94,76k | - |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | 9,02k | 0,00 | Derivative Exercise and Retained Stock | - | 26,52k | 51,58% |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -8,35k | 634,41k | Derivative Exercise and Sale | 75,95 | 26,52k | - |
| 2026-01-07 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -44,20k | 1,50M | Derivative Exercise and Sale | 32,60 - 85,36 | 17,49k | - |
| 2026-01-02 | Dr. Eric E. SwayzeExec. VP of Research | -23,46k | 427,66k | Derivative Exercise and Sale | 60,89 - 79,27 | 30,71k | - |
| 2025-12-01 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 2,26M | Automatic Disposition | 80,67 - 81,23 | 52,04k | -34,98% |
| 2025-11-25 | Mr. Joseph KleinIndependent Director | -12,00k | 960,00k | Derivative Exercise and Sale | 80,00 | 16,45k | - |
| 2025-11-25 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -16,78k | 455,34k | Derivative Exercise and Sale | 53,77 - 80,91 | 17,49k | - |
| 2025-11-19 | Ms. Joan Elizabeth HermanIndependent Director | -44,00k | 648,43k | Derivative Exercise and Sale | 40,05 - 72,13 | 46,09k | - |
| 2025-11-18 | Mr. Joseph Harris WenderLead Independent Director | 16,00k | 390,72k | Derivative Exercise and Retained Stock | 24,42 | 80,04k | 24,99% |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -70,93k | 1,15M | Derivative Exercise and Sale | 56,78 - 75,11 | 59,66k | - |
| 2025-11-05 | Dr. Richard S. GearyStrategic Consultant | -34,64k | 576,51k | Derivative Exercise and Sale | 56,78 - 76,10 | 59,66k | - |
| 2025-11-06 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8,00k | 609,38k | Automatic Disposition | 76,17 | 48,83k | -14,08% |
| 2025-10-31 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16,00k | 366,15k | Derivative Exercise and Sale | 52,22 - 75,10 | 36,33k | - |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -20,00k | 1,50M | Automatic Disposition | 75,11 | 59,66k | -25,11% |
| 2025-10-30 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 2,07M | Automatic Disposition | 72,19 - 75,16 | 64,04k | -30,42% |
| 2025-10-06 | Dr. Brett P. MoniaFounder, CEO & Director | -437,00 | 30,27k | Automatic Disposition | 69,26 | 179,57k | -0,24% |
| 2025-10-06 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1,63k | 112,73k | Automatic Disposition | 69,37 | 33,37k | -4,64% |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10,20k | 173,58k | Derivative Exercise and Sale | 52,87 - 69,89 | 53,89k | - |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -3,24k | 224,49k | Automatic Disposition | 69,27 | 53,89k | -5,67% |
| 2025-10-06 | Dr. Eric E. SwayzeExec. VP of Research | -6,85k | 472,72k | Automatic Disposition | 69,02 | 30,64k | -18,27% |
| 2025-10-02 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -15,00k | 543,21k | Derivative Exercise and Sale | 31,80 - 68,01 | 35,00k | - |
| 2025-10-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -64,66k | 563,80k | Derivative Exercise and Sale | 56,78 - 67,69 | 57,13k | - |
| 2025-10-01 | Mr. Joseph Harris WenderLead Independent Director | -16,80k | 1,10M | Automatic Disposition | 65,50 | 92,04k | -15,44% |
| 2025-10-01 | Dr. Eric E. SwayzeExec. VP of Research | -27,11k | 335,82k | Derivative Exercise and Sale | 53,77 - 66,23 | 37,49k | - |
| 2025-09-29 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -25,30k | 198,39k | Derivative Exercise and Sale | 56,78 - 64,68 | 57,13k | - |
| 2025-09-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -49,80k | 571,99k | Derivative Exercise and Sale | 53,77 - 65,26 | 110,50k | - |
| 2025-09-30 | Dr. Richard S. GearyStrategic Consultant | -57,90k | 664,39k | Derivative Exercise and Sale | 53,77 - 65,24 | 79,66k | - |
| 2025-09-12 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -1,70k | 13,26k | Derivative Exercise and Sale | 56,78 - 64,58 | 57,13k | - |
| 2025-09-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -21,00k | 81,08k | Derivative Exercise and Sale | 56,78 - 64,56 | 57,13k | - |
| 2025-09-09 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -11,95k | 362,83k | Derivative Exercise and Sale | 31,80 - 62,16 | 35,00k | - |
| 2025-09-05 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -250,00 | 7,55k | Derivative Exercise and Sale | 31,80 - 62,00 | 35,00k | - |
| 2025-09-05 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -6,00k | 357,58k | Automatic Disposition | 59,60 | 82,68k | -6,77% |
| 2025-09-02 | Dr. Eric E. SwayzeExec. VP of Research | -11,13k | 552,86k | Automatic Disposition | 49,22 - 53,68 | 37,49k | -22,89% |
| 2025-09-02 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 1,61M | Automatic Disposition | 55,04 - 60,14 | 108,84k | -20,46% |
| 2025-09-02 | Ms. B. Lynne ParshallDirector | -20,00k | 1,02M | Automatic Disposition | 50,42 - 51,49 | 66,34k | -23,16% |
| 2025-09-03 | Dr. Brett P. MoniaFounder, CEO & Director | -203,81k | 3,26M | Derivative Exercise and Sale | 32,60 - 61,06 | 180,01k | - |
| 2025-09-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3,16k | 78,74k | Derivative Exercise and Sale | 32,60 - 61,02 | 15,94k | - |
| 2025-09-02 | Dr. Richard S. GearyStrategic Consultant | -10,00k | 503,67k | Automatic Disposition | 50,37 | 79,66k | -11,15% |
| 2025-09-03 | Mr. Joseph KleinIndependent Director | -28,00k | 1,68M | Derivative Exercise and Sale | 60,00 | 16,45k | - |
| 2025-09-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -32,80k | 903,18k | Derivative Exercise and Sale | 31,80 - 62,01 | 35,00k | - |
| 2025-09-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16,00k | 571,65k | Derivative Exercise and Sale | 24,42 - 60,15 | 36,33k | - |
| 2025-09-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -89,90k | 1,34M | Derivative Exercise and Sale | 32,60 - 61,42 | 57,13k | - |
| 2025-09-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -46,80k | 331,92k | Derivative Exercise and Sale | 53,77 - 61,50 | 88,68k | - |
| 2025-09-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5,00k | 245,70k | Automatic Disposition | 49,14 | 88,68k | -5,34% |
| 2025-09-03 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -19,66k | 138,41k | Derivative Exercise and Sale | 53,77 - 61,42 | 51,51k | - |
| 2025-08-22 | Ms. Allene Maria DiazIndependent Director | -1,43k | 60,69k | Automatic Disposition | 42,53 | 18,37k | -7,21% |
| 2025-08-18 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -10,00k | 113,78k | Derivative Exercise and Sale | 32,60 - 43,98 | 93,47k | - |
| 2025-08-06 | Ms. B. Lynne ParshallDirector | -5,00k | 209,65k | Automatic Disposition | 41,87 - 42,63 | 86,34k | -5,47% |
| 2025-08-05 | Dr. Richard S. GearyStrategic Consultant | -10,00k | 428,59k | Automatic Disposition | 42,86 | 89,49k | -10,05% |
| 2025-08-04 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9,55k | 408,70k | Automatic Disposition | 42,80 | 51,51k | -15,64% |
| 2025-07-30 | Dr. Brett P. MoniaFounder, CEO & Director | -2,43k | 30,16k | Derivative Exercise and Sale | 32,60 - 45,00 | 179,82k | - |
| 2025-07-15 | Dr. Joseph LoscalzoIndependent Chairman of the Board | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 36,33k | 12,65% |
| 2025-07-15 | Mr. Joseph Harris WenderLead Independent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 136,84k | 3,07% |
| 2025-07-15 | Mr. Michael J. YangIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 6,01k | 211,24% |
| 2025-07-15 | Dr. Spencer Robert BerthelsenIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 156,08k | 2,68% |
| 2025-07-15 | Dr. Michael R. HaydenIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 56,30k | 7,81% |
| 2025-07-15 | Ms. Allene Maria DiazIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 19,80k | 25,95% |
| 2025-07-15 | Ms. Joan Elizabeth HermanIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 46,09k | 9,71% |
| 2025-07-15 | Ms. B. Lynne ParshallDirector | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 91,34k | 4,67% |
| 2025-07-11 | Dr. Brett P. MoniaFounder, CEO & Director | -1,16k | 48,42k | Automatic Disposition | 41,74 | 179,82k | -0,64% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
